183 related articles for article (PubMed ID: 26271140)
1. Inhibition of tumor energy pathways for targeted esophagus cancer therapy.
Shafaee A; Dastyar DZ; Islamian JP; Hatamian M
Metabolism; 2015 Oct; 64(10):1193-8. PubMed ID: 26271140
[TBL] [Abstract][Full Text] [Related]
2. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
3. Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.
Mathupala SP
Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):6-14. PubMed ID: 21110820
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
Ooi AT; Gomperts BN
Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
[TBL] [Abstract][Full Text] [Related]
5. Targeting AMPK in the treatment of malignancies.
Vakana E; Altman JK; Platanias LC
J Cell Biochem; 2012 Feb; 113(2):404-9. PubMed ID: 21928327
[TBL] [Abstract][Full Text] [Related]
6. Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response.
Gill KS; Fernandes P; O'Donovan TR; McKenna SL; Doddakula KK; Power DG; Soden DM; Forde PF
Biochim Biophys Acta; 2016 Aug; 1866(1):87-105. PubMed ID: 27373814
[TBL] [Abstract][Full Text] [Related]
7. Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets.
Ononye SN; Shi W; Wali VB; Aktas B; Jiang T; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2014 Dec; 148(3):477-88. PubMed ID: 25395317
[TBL] [Abstract][Full Text] [Related]
8. Novel ginsenoside derivative 20(S)-Rh2E2 suppresses tumor growth and metastasis in vivo and in vitro via intervention of cancer cell energy metabolism.
Huang Q; Zhang H; Bai LP; Law BYK; Xiong H; Zhou X; Xiao R; Qu YQ; Mok SWF; Liu L; Wong VKW
Cell Death Dis; 2020 Aug; 11(8):621. PubMed ID: 32796841
[TBL] [Abstract][Full Text] [Related]
9. Metformin, cancer and glucose metabolism.
Salani B; Del Rio A; Marini C; Sambuceti G; Cordera R; Maggi D
Endocr Relat Cancer; 2014; 21(6):R461-71. PubMed ID: 25273809
[TBL] [Abstract][Full Text] [Related]
10. 6-mercaptopurine promotes energetic failure in proliferating T cells.
Fernández-Ramos AA; Marchetti-Laurent C; Poindessous V; Antonio S; Laurent-Puig P; Bortoli S; Loriot MA; Pallet N
Oncotarget; 2017 Jun; 8(26):43048-43060. PubMed ID: 28574837
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function.
Mouradian M; Kikawa KD; Dranka BP; Komas SM; Kalyanaraman B; Pardini RS
Mol Carcinog; 2015 Sep; 54(9):810-20. PubMed ID: 24729481
[TBL] [Abstract][Full Text] [Related]
12. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
13. Adenosine monophosphate-activated kinase and its key role in catabolism: structure, regulation, biological activity, and pharmacological activation.
Krishan S; Richardson DR; Sahni S
Mol Pharmacol; 2015; 87(3):363-77. PubMed ID: 25422142
[TBL] [Abstract][Full Text] [Related]
14. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.
Talekar M; Boreddy SR; Singh A; Amiji M
Expert Opin Biol Ther; 2014 Aug; 14(8):1145-59. PubMed ID: 24762115
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
[TBL] [Abstract][Full Text] [Related]
16. The multifaceted activities of AMPK in tumor progression--why the "one size fits all" definition does not fit at all?
Bonini MG; Gantner BN
IUBMB Life; 2013 Nov; 65(11):889-96. PubMed ID: 24265196
[TBL] [Abstract][Full Text] [Related]
17. Energy homeostasis and cancer prevention: the AMP-activated protein kinase.
Fay JR; Steele V; Crowell JA
Cancer Prev Res (Phila); 2009 Apr; 2(4):301-9. PubMed ID: 19336731
[TBL] [Abstract][Full Text] [Related]
18. Adenosine monophosphate-activated protein kinase: a central regulator of metabolism with roles in diabetes, cancer, and viral infection.
Hardie DG
Cold Spring Harb Symp Quant Biol; 2011; 76():155-64. PubMed ID: 22071265
[TBL] [Abstract][Full Text] [Related]
19. [AMPK as a cellular energy sensor and its function in the organism].
Miranda N; Tovar AR; Palacios B; Torres N
Rev Invest Clin; 2007; 59(6):458-69. PubMed ID: 18402338
[TBL] [Abstract][Full Text] [Related]
20. Alpha linolenic acid and oleic acid additively down-regulate malignant potential and positively cross-regulate AMPK/S6 axis in OE19 and OE33 esophageal cancer cells.
Moon HS; Batirel S; Mantzoros CS
Metabolism; 2014 Nov; 63(11):1447-54. PubMed ID: 25129649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
